Cargando…
Prognostic value of postoperative ctDNA detection in patients with early non-small cell lung cancer: a systematic review and meta-analysis
BACKGROUND: Circulating tumor DNA (ctDNA) has emerged as a potential biomarker for monitoring early non-small cell lung cancer (ENSCLC), particularly after radical surgery. However, the prognostic value of postoperative ctDNA is still being investigated due to the small sample size and heterogeneity...
Autores principales: | Guo, Kaibo, Lu, Jiamin, Lou, Yidan, Zheng, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226303/ https://www.ncbi.nlm.nih.gov/pubmed/37256023 http://dx.doi.org/10.1177/17588359231177008 |
Ejemplares similares
-
Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis
por: Mittal, Abhenil, et al.
Publicado: (2023) -
The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
por: Li, Mengjie, et al.
Publicado: (2022) -
Prognostic Value of Pretreatment D-Dimer Level in Small-Cell Lung Cancer: A Meta-Analysis
por: Li, Jialong, et al.
Publicado: (2021) -
The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
por: Lu, Yuanyuan, et al.
Publicado: (2021) -
Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis
por: Tuminello, Stephanie, et al.
Publicado: (2019)